methylprednisolone has been researched along with trinitrobenzenesulfonic acid in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anthony, D; Boulos, P; Hembry, R; Sams, V; Savage, F; Trevethick, M | 1 |
| Choi, B; Han, J; Hong, S; Jung, Y; Kim, YM; Kong, H; Lee, Y | 1 |
| Akpinar, H; Baskin, H; Sagol, O; Saygili, F; Saygili, SM; Soyturk, M; Yilmaz, O | 1 |
| Akbay Karatay, E; Arhan, M; Ekinci, O; Erdal, H; Gul Utku, O; Ibis, M; Onal, IK; Unal, S; Yilmaz Demirtas, C | 1 |
4 other study(ies) available for methylprednisolone and trinitrobenzenesulfonic acid
| Article | Year |
|---|---|
Effect of methylprednisolone on the ulceration, matrix metalloproteinase distribution and eicosanoid production in a model of colitis in the rabbit.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Anti-Inflammatory Agents; Colitis; Colon; Dinoprostone; Disease Models, Animal; Eicosanoids; Leukocyte Count; Leukotriene B4; Metalloendopeptidases; Methylprednisolone; Neutrophils; Rabbits; Random Allocation; Trinitrobenzenesulfonic Acid | 1997 |
Sulfate-conjugated methylprednisolone as a colon-targeted methylprednisolone prodrug with improved therapeutic properties against rat colitis.
Topics: Administration, Oral; Adrenal Glands; Animals; Colitis; Colon; Disease Models, Animal; Drug Delivery Systems; Glucocorticoids; Male; Methylprednisolone; Prodrugs; Rats; Rats, Sprague-Dawley; Sulfates; Thymus Gland; Trinitrobenzenesulfonic Acid | 2009 |
Effectiveness of Saccharomyces boulardii in a rat model of colitis.
Topics: Animals; Anti-Inflammatory Agents; Colitis; Colon; Disease Models, Animal; Female; Gastrointestinal Agents; Inflammation Mediators; Methylprednisolone; Nitric Oxide; Probiotics; Rats; Rats, Wistar; Saccharomyces; Time Factors; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2012 |
Rivaroxaban Induces Mucosal Healing in a Rat Model of Trinitrobenzene Sulfonic Acid-Induced Colitis.
Topics: Animals; Colitis; Disease Models, Animal; Factor Xa Inhibitors; Female; Immunosuppressive Agents; Intestinal Mucosa; Malondialdehyde; Methylprednisolone; Rats; Rats, Wistar; Rivaroxaban; Transforming Growth Factor beta1; Trinitrobenzenesulfonic Acid; Wound Healing | 2015 |